STAAR Surgical | STAA - Ebitda

Aktienkurs
25.67
Täglich Wechseln
0.83 3.34%
Monatlich
33.77%
Jährlich
42.37%
Q2 Prognose
25.12




Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
Bausch Health Companies USD 986M 74M 2025-09
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
J&J USD 7.19B 2.32B 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Novartis USD 4.77B 1.11B 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Orthofix International USD 27.88M 2.77M 2025-12
STAAR Surgical USD -159K 34.78M 2025-12